Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.54
-0.17 (-1.02%)
At close: Jun 27, 2025, 4:00 PM
16.16
-0.38 (-2.30%)
After-hours: Jun 27, 2025, 5:40 PM EDT

Tourmaline Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
425520532--
Market Cap Growth
-33.48%-2.33%---
Enterprise Value
176238583--
Last Close Price
16.5420.2826.18--
PB Ratio
1.521.732.60--
P/TBV Ratio
1.521.732.60--
Debt / Equity Ratio
0.000.000.000.07-0.66
Quick Ratio
32.7128.9940.576.060.40
Current Ratio
33.8730.1841.766.100.40
Return on Equity (ROE)
-26.14%-28.99%-39.66%-549.77%-
Return on Assets (ROA)
-19.03%-21.60%-25.87%-266.29%-
Return on Capital (ROIC)
-19.39%-22.18%-26.60%-314.87%-
Earnings Yield
-19.50%-14.08%-7.91%--
FCF Yield
-19.78%-14.86%-5.29%--
Buyback Yield / Dilution
-144.29%-433.98%-441.28%91.94%-
Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q